Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK
Search for other papers by Sirazum Choudhury in
Google Scholar
PubMed
Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK
Search for other papers by Tricia Tan in
Google Scholar
PubMed
Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK
Search for other papers by Katharine Lazarus in
Google Scholar
PubMed
Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK
Search for other papers by Karim Meeran in
Google Scholar
PubMed
-fold increase in mortality when associated with adrenal insufficiency ( 8 ). Taken together, these data suggest that the mortality gap in hypoadrenalism is not just limited to primary disease. Possible causes of the mortality gap The cause of the
Diabetes and Endocrine Clinic, Mediclinic Airport Road Hospital, Abu Dhabi, United Arab Emirates
Search for other papers by Salem A Beshyah in
Google Scholar
PubMed
Search for other papers by Khawla F Ali in
Google Scholar
PubMed
Search for other papers by Hussein F Saadi in
Google Scholar
PubMed
–10 hypoadrenal patients per year, while 22.1% see 11–25 patients per year ( Table 3 ). Most respondents (78.6%) prescribed hydrocortisone, while the minority prescribed other preparations for replacement therapy ( Table 3 ). The glucocorticoid doses were
Search for other papers by Thabiso R P Mofokeng in
Google Scholar
PubMed
Department of Endocrinology, Mediclinic Airport Road Hospital, Abu Dhabi, United Arab Emirates
Search for other papers by Salem A Beshyah in
Google Scholar
PubMed
Search for other papers by Fazleh Mahomed in
Google Scholar
PubMed
Search for other papers by Kwazi C Z Ndlovu in
Google Scholar
PubMed
Search for other papers by Ian L Ross in
Google Scholar
PubMed
survey, manage patients with hypoadrenalism (Supplementary Appendix 1). The respondents were mostly non-endocrine specialists (48.8%) and primary care doctors (33.3%) and the minority (17.6%) were specialist endocrinologists. The proportion who identified
Division of Endocrinology, Mid and South Essex NHS Trust, Broomfield, UK
Search for other papers by Saroj Kumar Sahoo in
Google Scholar
PubMed
Search for other papers by Jayakrishnan C Menon in
Google Scholar
PubMed
Search for other papers by Nidhi Tripathy in
Google Scholar
PubMed
Search for other papers by Monalisa Nayak in
Google Scholar
PubMed
Search for other papers by Subhash Yadav in
Google Scholar
PubMed
patients with severe COVID-19 by reducing the impact of cytokine storm. Glucocorticoids could also have improved the outcome by addressing the underlying COVID-19-induced hypoadrenalism, at least in a subset of patients. Screening of patients with COVID-19
Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK
Search for other papers by Angelica Sharma in
Google Scholar
PubMed
Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK
Search for other papers by Katharine Lazarus in
Google Scholar
PubMed
Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK
Search for other papers by Deborah Papadopoulou in
Google Scholar
PubMed
Search for other papers by Hemanth Prabhudev in
Google Scholar
PubMed
Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK
Department of Clinical Biochemistry, North West London Pathology, London, UK
Search for other papers by Tricia Tan in
Google Scholar
PubMed
Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK
Search for other papers by Karim Meeran in
Google Scholar
PubMed
Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK
Department of Clinical Biochemistry, North West London Pathology, London, UK
Search for other papers by Sirazum Choudhury in
Google Scholar
PubMed
insufficiency. Discussion This is the largest dataset of prednisolone pharmacokinetics in patients with hypoadrenalism and demonstrates that once-daily very-low-dose prednisolone is a safe and effective glucocorticoid replacement therapy. Dose
National Center for Neurological Disorders, Shanghai, China
Shanghai Clinical Medical Center of Neurosurgery, Shanghai, China
Neurosurgical Institute of Fudan University, Shanghai, China
Shanghai Key Laboratory of Brain Function and Restoration and Neural Regeneration, Shanghai, China
Search for other papers by Nidan Qiao in
Google Scholar
PubMed
Search for other papers by Haixia Cheng in
Google Scholar
PubMed
Search for other papers by Zhaoyun Zhang in
Google Scholar
PubMed
Search for other papers by Hongying Ye in
Google Scholar
PubMed
National Center for Neurological Disorders, Shanghai, China
Shanghai Clinical Medical Center of Neurosurgery, Shanghai, China
Neurosurgical Institute of Fudan University, Shanghai, China
Shanghai Key Laboratory of Brain Function and Restoration and Neural Regeneration, Shanghai, China
Search for other papers by Ming Shen in
Google Scholar
PubMed
National Center for Neurological Disorders, Shanghai, China
Shanghai Clinical Medical Center of Neurosurgery, Shanghai, China
Neurosurgical Institute of Fudan University, Shanghai, China
Shanghai Key Laboratory of Brain Function and Restoration and Neural Regeneration, Shanghai, China
Search for other papers by Xuefei Shou in
Google Scholar
PubMed
National Center for Neurological Disorders, Shanghai, China
Shanghai Clinical Medical Center of Neurosurgery, Shanghai, China
Neurosurgical Institute of Fudan University, Shanghai, China
Shanghai Key Laboratory of Brain Function and Restoration and Neural Regeneration, Shanghai, China
Search for other papers by Xiaoyun Cao in
Google Scholar
PubMed
National Center for Neurological Disorders, Shanghai, China
Shanghai Clinical Medical Center of Neurosurgery, Shanghai, China
Neurosurgical Institute of Fudan University, Shanghai, China
Shanghai Key Laboratory of Brain Function and Restoration and Neural Regeneration, Shanghai, China
Department of Pathology, Huashan Hospital, Shanghai Medical School, Shanghai, China
Search for other papers by Hong Chen in
Google Scholar
PubMed
National Center for Neurological Disorders, Shanghai, China
Shanghai Clinical Medical Center of Neurosurgery, Shanghai, China
Neurosurgical Institute of Fudan University, Shanghai, China
Shanghai Key Laboratory of Brain Function and Restoration and Neural Regeneration, Shanghai, China
Search for other papers by Xiang Zhou in
Google Scholar
PubMed
National Center for Neurological Disorders, Shanghai, China
Shanghai Clinical Medical Center of Neurosurgery, Shanghai, China
Neurosurgical Institute of Fudan University, Shanghai, China
Shanghai Key Laboratory of Brain Function and Restoration and Neural Regeneration, Shanghai, China
Search for other papers by Yongfei Wang in
Google Scholar
PubMed
National Center for Neurological Disorders, Shanghai, China
Shanghai Clinical Medical Center of Neurosurgery, Shanghai, China
Neurosurgical Institute of Fudan University, Shanghai, China
Shanghai Key Laboratory of Brain Function and Restoration and Neural Regeneration, Shanghai, China
Search for other papers by Yao Zhao in
Google Scholar
PubMed
.9%) 20 (71.4%) 7 (63.6%) 2 (16.7%) 0.005 Pre-operative endocrine assessment Hypothyroidism 16 (32.4%) 9 (32.1%) 3 (26.3%) 4 (33.3%) 1.000 Hypoadrenalism 15 (29.4%) 6 (21.4%) 4 (36.4%) 5 (41.7%) 0
Search for other papers by C E Higham in
Google Scholar
PubMed
The University of Liverpool, Brownlow Hill, Liverpool, UK
Search for other papers by A Olsson-Brown in
Google Scholar
PubMed
Search for other papers by P Carroll in
Google Scholar
PubMed
Search for other papers by T Cooksley in
Google Scholar
PubMed
Search for other papers by J Larkin in
Google Scholar
PubMed
Search for other papers by P Lorigan in
Google Scholar
PubMed
Search for other papers by D Morganstein in
Google Scholar
PubMed
Search for other papers by P J Trainer in
Google Scholar
PubMed
Search for other papers by the Society for Endocrinology Clinical Committee in
Google Scholar
PubMed
, mineralocorticoid replacement (fludrocortisone) may be needed once daily glucocorticoid dose is below 50 mg hydrocortisone/24 h or equivalent. This is not required for hypophysitis and other causes of secondary hypoadrenalism. A short Synacthen test may be
Endocrine Disease Unit, University-Hospital of Padova, Padova, Italy
Department of Neuroscience DNS, University of Padova, Padova, Italy
Search for other papers by Filippo Ceccato in
Google Scholar
PubMed
Search for other papers by Elisa Selmin in
Google Scholar
PubMed
Laboratory Medicine, University-Hospital of Padova, Padova, Italy
Search for other papers by Giorgia Antonelli in
Google Scholar
PubMed
Endocrine Disease Unit, University-Hospital of Padova, Padova, Italy
Department of Neuroscience DNS, University of Padova, Padova, Italy
Search for other papers by Mattia Barbot in
Google Scholar
PubMed
Search for other papers by Andrea Daniele in
Google Scholar
PubMed
Search for other papers by Marco Boscaro in
Google Scholar
PubMed
Laboratory Medicine, University-Hospital of Padova, Padova, Italy
Search for other papers by Mario Plebani in
Google Scholar
PubMed
Endocrine Disease Unit, University-Hospital of Padova, Padova, Italy
Search for other papers by Carla Scaroni in
Google Scholar
PubMed
and Metabolism 2008 93 4245 – 4253 . ( https://doi.org/10.1210/jc.2008-0710 ) 5 Crowley RK Argese N Tomlinson JW Stewart PM . Central hypoadrenalism . Journal of Clinical Endocrinology and Metabolism 2014 99 4027 – 4036 . ( https
Endocrinology Department, University Hospital in Krakow, Krakow, Poland
Search for other papers by Aleksandra Gilis-Januszewska in
Google Scholar
PubMed
Endocrinology Department, University Hospital in Krakow, Krakow, Poland
Search for other papers by Łukasz Kluczyński in
Google Scholar
PubMed
Endocrinology Department, University Hospital in Krakow, Krakow, Poland
Search for other papers by Alicja Hubalewska-Dydejczyk in
Google Scholar
PubMed
). Since hypoadrenalism is potentially life-threatening, hormone replacement therapy should be introduced immediately. It should be noted that cortisolemia may be affected by drugs (i.e. etomidate, propofol) that were administered in the intensive care
Waikato Clinical Campus, University of Auckland, Hamilton, New Zealand
Search for other papers by M S Elston in
Google Scholar
PubMed
Search for other papers by V B Crawford in
Google Scholar
PubMed
Search for other papers by M Swarbrick in
Google Scholar
PubMed
Search for other papers by M S Dray in
Google Scholar
PubMed
Search for other papers by M Head in
Google Scholar
PubMed
Search for other papers by J V Conaglen in
Google Scholar
PubMed
adrenal blockade and watch for the development of hypoadrenalism ( 10 ). In a multicentre study of 195 patients including 37 patients with EAS, where 164 patients received metyrapone monotherapy, biochemical monitoring showed improvement in all cases with